Promising drug targets Hard-to-Treat breast cancer in chinese patients
NCT ID NCT04454437
First seen Feb 02, 2026 · Last updated May 25, 2026 · Updated 13 times
Summary
This study tests a drug called sacituzumab govitecan in 80 Chinese patients with metastatic triple-negative breast cancer who have already tried at least two other treatments. The goal is to see if the drug can shrink tumors or slow the disease. This is a phase 2 trial, meaning it is still being studied for effectiveness and safety.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC TRIPLE-NEGATIVE BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Anhui Provincial Hospital
Hefei, 230001, China
-
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Beijing, Beijing Municipality, 100021, China
-
Chinese PLA General Hospital
Beijing, 100853, China
-
Chongqing University Cancer Hospital
Chongqing, 404100, China
-
Hubei Cancer Hospital
Wuhan, 430000, China
-
Hunan Cancer Hospital
Changsha, 410013, China
-
Liaoning Cancer Hospital & Institute
Shenyang, Liaoning, China
-
Sir Run Run Shaw Hospital, Zhejiang University, School of Medicine
Hangzhou, Zhejiang, China
-
Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University
Guangzhou, 510120, China
-
Sun Yat-sen University, Cancer Center
Guangzhou, 510000, China
-
The First Affiliated Hospital of Anhui Medical University
Hefei, 230022, China
-
The First Affiliated Hospital of Xi'an Jiaotong University
Xi'an, 710061, China
-
The First Hospital of China Medical University
Shenyang, 110001, China
-
The First Hospital of Jilin University
Changchun, 130021, China
-
Tianjin Medical University Cancer Institute & Hospital
Tianjin, 300060, China
-
West China Hospital, Sichuan University
Chengdu, China
-
Zhejiang Cancer Hospital
Hangzhou, 310022, China
Conditions
Explore the condition pages connected to this study.